A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.

Michael T GundesenJon T AsmussenEinar HaukåsMichael SchubertNiels AbildgaardSchjesvold FredrikThomas Lund

Published in: European journal of haematology (2022)

WBLDCT outperformed CSS for finding progressive bone disease and osteolytic lesions. More new lesions were found during follow-up by WBLDCT than CSS. Using CSS for lytic lesions will underestimate progression rates. Our data offer prospective evidence for the current recommendation using WBLDCT for skeletal evaluations in patients with multiple myeloma.

Keyphrases

multiple myeloma
low dose
multiple sclerosis
computed tomography
magnetic resonance imaging
cross sectional
big data
machine learning
image quality
artificial intelligence
postmenopausal women
bone loss
data analysis